GlassScriptPhysician profile
John Travis Blakemore
NPI 1548837610
$15,210.23
in general payments reported to CMS, 2019-2025
48 companies · $1,180 in 2025
The $1,180 reported for 2025 was more than what 88% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $3,871 · 2023: $5,015 · 2024: $5,144 · 2025: $1,180.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Travel and Lodging: $898 · Consulting Fee: $150 · Education: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,180.61 |
| Travel and Lodging | $897.90 |
| Consulting Fee | $150.00 |
| Education | $111.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $2,136.42 | 2022-2025 | Vumerity, Tysabri, Tysabri |
| Ucb, INC. | $1,551.67 | 2022-2025 | Briviact, Fintepla, Rystiggo |
| Livanova USA, INC. | $1,400.66 | 2024 | Vns Therapy |
| Novartis Pharmaceuticals Corporation | $1,211.11 | 2022-2024 | |
| Sk Life Science, INC. | $1,095.81 | 2022-2025 | Xcopri |
| Emd Serono, INC. | $711.69 | 2022-2024 | Mavenclad, Mavenclad |
| Abbvie INC. | $657.10 | 2022-2025 | |
| Genentech USA, INC. | $400.22 | 2022-2025 | Ocrevus, Enspryng, Ocrevus Zunovo |
| Horizon Therapeutics Plc | $397.03 | 2022-2023 | Uplizna |
| Corium, LLC | $388.75 | 2023 | Adlarity, Azstarys |
| Neurelis, INC. | $380.03 | 2022-2024 | Valtoco |
| Amgen INC. | $349.61 | 2022-2024 | Uplizna |
| Eisai INC. | $342.29 | 2022-2024 | |
| Jazz Pharmaceuticals INC. | $289.89 | 2023-2025 | |
| Acadia Pharmaceuticals INC | $285.02 | 2022-2024 | Daybue, Nuplazid |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Blakemore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.